CircoMax RSSAuthorisedThis medicine is authorised for use in the European Unionporcine circovirus vaccine (inactivated recombinant)MedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on CircoMaxApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine CircoMax Active substance Recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2a open reading frame 2 protein, inactivated,Recombinant chimeric porcine circovirus 1 containing the porcine circovirus 2b open reading frame 2 protein, inactivated International non-proprietary name (INN) or common name porcine circovirus vaccine (inactivated recombinant) Pharmacotherapeutic groupImmunologicals for suidaeInactivated viral vaccinesAuthorisation details EMA product number EMEA/V/C/005185 Assessment historyExpand sectionCollapse sectionChanges since initial authorisation of medicineCVMP post-authorisation summary of positive for CircoMaxAdoptedReference Number: EMA/CVMP/452706/2023 English (EN) (137.73 KB - PDF)First published: 06/10/2023ViewInitial marketing authorisation documentsCVMP summary of positive opinion for CircoMaxAdoptedReference Number: EMA/CVMP/617167/2021 English (EN) (132.49 KB - PDF)First published: 08/11/2021ViewNews on CircoMaxMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 202314/07/2023Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 202207/10/2022Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 202108/11/2021This page was last updated on 15/02/2024Share this page